INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2021

In patients with knee osteoarthritis, 500 mg/day of resveratrol for 90 days improved aggrecan levels, pain, and KOOS scores, but not Coll 2-1.

An open-labeled noncontrolled clinical trial evaluated the effect of 500 mg/day oral resveratrol monotherapy for 90 days in knee osteoarthritis patients. Resveratrol administration led to a nonsignificant decrease in serum Coll 2-1 and a significant increase in serum aggrecan. Pain scores measured by VAS and KOOS significantly improved after 30 days, alongside significant improvements in all KOOS subscale areas that persisted through three months.

Study type
Open-labeled noncontrolled clinical trial
Who was studied
Patients with knee osteoarthritis (sample size not stated)
What was measured
Serum Coll 2-1, aggrecan, inflammation markers, safety markers, VAS, and KOOS

THE PAPER

Effect of Resveratrol on Serum Levels of Type II Collagen and Aggrecan in Patients with Knee Osteoarthritis: A Pilot Clinical Study.

Marouf BH. Biomed Res Int, 2021.

PubMed 34805399 ↗DOI 10.1158/0008-5472.can-10-2364 ↗

Bones & musclesOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.